A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

Introducing a fashion line inspired by the two million Canadians affected by osteoporosis TORONTO, Feb. 6, 2019  – Models clad in stylish bubble wrap strutted down the Toronto Fashion Week® x […]

Vitamin D plays a significant role in building and maintaining healthy bones. In light of the current COVID-19 pandemic, the effects of vitamin D on the immune system are being […]

IMPACT REPORT 2020 – 2021 __________   PATIENT STORYJOYCE CRAWFORD Joyce’s father had osteoporosis and even though her grandmother wasn’t formally diagnosed, she had signs of the disease including her […]

IMPACT REPORT 2019 – 2020 PATIENT STORY: MEET MURRAY BOLTON For Murray, it all started with a broken wrist. The kind of accident that could happen to anyone, he reasoned. […]

Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, Dr. Emma Billington and Dr. Wendy Ward. Recommendations from Osteoporosis Canada Rapid Response Team. LeBoff and colleagues (1) […]

IMPACT REPORT 2017 – 2018 PATIENT STORY: MEET JUANITA GLEDHILL Juanita Gledhill had just celebrated her 50th birthday. During her annual physical, she asked her doctor for a bone density […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]